RIGL
NASDAQ · Biotechnology
Rigel Pharmaceuticals Inc
$51.29
+2.43 (+4.97%)
Analyst Consensus
Buy
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+5.5% upside
Low Target
$39.68
Average Target
$54.10
High Target
$74.39
Current Price
$51.29
Current
$51.29
$51.29
Target
$54.10
$54.10
$39.68
$54.10 avg
$74.39
Scenario Analysis
Bear Case
$39.68
-22.6%
Low target
Base Case
$54.10
+5.5%
Avg target
Bull Case
$74.39
+45.0%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$52.24
-1.8% from high
52-Week Low
$24.95
+105.6% from low
Target vs 52W High
$54.10
+3.6% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -10.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +116.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.2% |
| MRNA | Hold | 31 | 35% | $149.45 | -38.1% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -60.7% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -35.8% |